Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate

Publish date:: October 20, 2020

Key clinical point: Older age, relapsed/refractory (r/r) disease in lymphoma patients tied to an increased death rate from COVID-19.

Major finding: Patients younger than age 70 years, without r/r lymphoma had an 88% 30-day overall survival, comparable to the general population.

Study details: Retrospective database of all 89 adult patients with lymphoma who were hospitalized for COVID-19.

Disclosures: The study was unsponsored. Several of the authors reported financial relationships with a number of biotechnology and pharmaceutical companies.

Citation:

Lamurea S et al. EClinicalMedicine. 2020 Oct 12. doi: 10.1016/j.eclinm.2020.100549.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in COVID-19 Updates

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Obesity, hypoxia predict severity in children with COVID-19,

Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?,

COVID-19 in pregnancy raises risk of preterm birth and severe disease,

New case suggestive of in utero SARS-CoV-2 transmission,